Skip to content

← Back to Evidence

The Evidence Chain: Photon → Population

This register compares 57 component claims across 47 layers of BERM (VK1–VK31, VK41–VK56). It identifies 17 proposed feedback loops and the open bridges that prevent the components from constituting one verified photon-to-population mechanism.

This page audits BERM's proposed chain against published evidence. A confirmed row means that the named component is supported in its stated system; it does not automatically confirm either neighbouring cross-scale transition. Partial and open bridges determine the status of the complete route.

Component evidence and open bridges

BERM proposes a continuous causal chain from physical input to population outcomes. The table tests its components separately and must not be read as direct verification of the complete route.

10⁻¹⁵ m

Metric premise → biological observable

◐ Partial

Lindgren 2025i ansatz; derived χ_geo; conditional response operator

The inverse rank-one metric yields χ_geo for a normalized positive-norm mode. Under explicit matter–metric and linear-response assumptions, BERM also derives the operator form. The tissue kernel, sign, lag and endpoint calibration remain open, so the biological response is not yet established.

10⁻¹⁰ m

Candidate field response at an S4 voltage sensor

✓ Confirmed

Tang 2024i Nature Communications

Tang 2024 provides protocol-specific S4 conformational evidence. It supports an S4 response component but does not derive tissue coupling from Lindgren geometry or calibrate BERM's L2 kernel.

10⁻⁹ m

S4 → VGCC opens

✓ Confirmed

Panagopoulos 2025i IFO, Trus 2024i non-ionotropic

S4 conformational change triggers VGCC gating. Panagopoulos 2025 provides the mechanistic model; Trus 2024 demonstrates non-ionotropic (non-thermal) activation pathway.

10⁻⁹ m

VGCC → Ca²⁺ + Pb²⁺/Cd²⁺ permeation

✓ Confirmed

Marchetti 2013i, Cd→Cav3.1 radiolabeled

Open VGCCs allow Ca²⁺ influx — but also toxic metals. Cd²⁺ permeates through Cav3.1 (confirmed with ¹⁰⁹Cd²⁺ radiolabel). Pb²⁺ mimics Ca²⁺ at calmodulin binding sites.

10⁻⁸ m

Ca²⁺ → CaM → CaMKII

✓ Confirmed

Basic biochemistry (textbook)

Ca²⁺ binds calmodulin → activates CaMKII via Thr286 autophosphorylation. This is the convergence point: all upstream signals funnel through CaMKII.

10⁻⁷ m

CaMKII → TPH-2 → 5-HT change in brain

✓ Confirmed

900 MHzi → 5-HT region-specifically (hypothalamus, medulla)

CaMKII phosphorylates TPH-2 (tryptophan hydroxylase-2), the rate-limiting enzyme for brain serotonin synthesis. 900 MHz produces region-specific 5-HT changes in hypothalamus and medulla — the exact regions controlling sleep and cardiorespiratory function.

10⁻⁷ m

CaMKII → CSD threshold

✓ Confirmed

CaV + NMDAi both required; CaMKII inhibitioni → hyperexcitability

CaMKII regulates the threshold for cortical spreading depolarization (CSD). Both CaV channels and NMDA receptors are necessary for CSD initiation. CaMKII inhibition paradoxically increases excitability — precise regulation is critical.

10⁻⁶ m

ELF → VGCC expression↑ (ELF-priming)

✓ Confirmed

Sun 2016i Scientific Reports: 8-10 days → Ca²⁺ dramatically↑, Cav1 protein↑

Chronic ELF exposure (50/60 Hz) upregulates VGCC protein expression — more channels per cell → cells become more sensitive to ALL subsequent EMF. This is ELF-priming: the background 50 Hz grid sensitizes the population.

10⁻⁶ m

ELF → seizure susceptibility↑ in neocortex

✓ Confirmed

Varró 2009i: transient priming effect

ELF-EMF enhances synaptic facilitation in hippocampus AND increases seizure susceptibility in neocortex. The effect is transient — demonstrating that ELF modulates neuronal excitability acutely.

10⁻⁵ m

GABA excitatory → Q→∞ in neonatal brain

✓ Confirmed

PMC7847733i, bumetanide restores inhibition, KCC2 maturation

In neonates, NKCC1 dominance makes GABA excitatory (γ < 0). This means the Q-factor → ∞: the brain is an undamped resonator. Bumetanide blocks NKCC1 → GABA becomes inhibitory → seizures stop. KCC2 matures over months → Q decreases.

10⁻⁴ m

Primed + EMF → seizures

✓ Confirmed

López-Martín 2006i/2009i: pulse-modulated > CW

The key experiment: subconvulsive picrotoxin (reduces γ) + GSM 900 MHz = seizures. Neither alone suffices. Pulse-modulated GSM is more effective than continuous wave — biological effect depends on specific pulsation, not SAR.

10⁻³ m

CSD → brainstem → death

✓ Confirmed

SUDEP = 'adult SIDS'; CACNA1Ai model; L-type Ca²⁺ antagonisti PREVENTED death

Spreading depolarization propagating to brainstem causes cardiorespiratory arrest. This is SUDEP and SIDS. L-type VGCC antagonist prevented seizure-induced death in SUDEP mouse models — direct proof that Ca²⁺ blockade prevents the terminal event.

10⁻² m

Melatonin↓ → cardiac arrhythmia

✓ Confirmed

Pinealectomyi → arrhythmias↑; melatonin supplementation → protection

Pinealectomy increases reperfusion arrhythmias. Chronic melatonin supplementation provides arrhythmia protection via antifibrotic effects, Cx43 preservation, mitochondrial protection. EMF suppresses melatonin via CRY pathway → cardiac risk increases.

10⁻² m

PGC → melatonin↓ → pathology

✓ Confirmed

r=0.569i uncalcified tissue↔melatonin; AD: 76% vs 64%i PGC

Pineal gland calcification (PGC) directly reduces melatonin production (r=0.569). Alzheimer's patients have higher PGC (76% vs 64%). PGC is a convergent mechanism: EMF + heavy metals + fluoride all accelerate it.

10⁻² m

Sleep↓ → GABA↓ → Q↑

✓ Confirmed

Sleep deprivation activates epileptiform discharges in 23-62i%

Sleep deprivation reduces GABA tonic inhibition (γ decreases → Q increases). This is used clinically as diagnostic provocation for epilepsy. EMF→melatonin↓→sleep↓→GABA↓ creates feedback loop 4 (Walker chain).

10⁻¹ m

Prenatal Ca²⁺ disruption → offspring γ↓

◐ Partial

Sevofluranei → interneuron disruption → γ↓ permanently

Maternal sevoflurane (Ca²⁺ modulator) disrupts interneuron development → permanent GABAergic inhibition deficit in offspring. Demonstrates prenatal Ca²⁺ disruption can permanently alter damping. Partial: mechanism shown with sevoflurane, not yet with EMF directly.

10⁰ m

Pharmacology targets Ca²⁺ cascade

✓ Confirmed

Ethosuximide, gabapentin, verapamil, melatonin, lithium, psilocybin, bumetanide

Every effective treatment for BERM-predicted conditions targets a component of the Ca²⁺ cascade. This pharmacological convergence is predicted by the model and would be extraordinary coincidence otherwise.

10³ m

Epidemiological elimination

◐ Partial

Klimentidisi p=10⁻⁷ (8 species), Mazuri weight-stable T↓, 54-country R²=0.851

Cross-species obesity trend (8 species, p=10⁻⁷) eliminates diet/exercise as sole cause. 54-country EMF-health correlation R²=0.851. Partial: epidemiological evidence is correlational, not interventional.

10⁻⁶ m

VK9: EMF → BBB permeability↑

✓ Confirmed

PMC12829706i: RF → eNOS↑ + occludin↓; melatonin protects (PMC6932927i)

RF-EMF increases blood-brain barrier permeability via eNOS upregulation and occludin downregulation. Melatonin protects tight junction proteins. EMF→melatonin↓ creates double BBB vulnerability: direct opening + loss of melatonin protection.

10⁻⁵ m

VK10: 5G → BAT PRDM16↓ → thermogenesis↓

✓ Confirmed

PMC11942954i: 3.5 GHz → PRDM16↓, C/EBPβ↓

5G (3.5 GHz) reduces PRDM16 and C/EBPβ mRNA in brown adipose tissue. BAT uses Ca²⁺ cycling (SERCA) for thermogenesis — a VGCC-mediated mechanism. Connects EMF to the Klimentidis obesity paradox: 8 species gaining weight without dietary change (p=10⁻⁷).

10⁻³ m

VK11: EMF → HPA axis → cortisol↑

✓ Confirmed

Klimek 2023i: ELF → HPA sensitization; RF → corticosterone↑ (Frontiers 2026i)

ELF-EMF sets a new HPA axis setpoint with sensitization rather than adaptation. RF-EMF increases anxiety and corticosterone. The HPA axis does NOT habituate to chronic EMF — it sensitizes, producing progressively higher cortisol baseline.

10⁻⁵ m

VK12: EMF → β-cell Ca²⁺ → insulin disrupted

✓ Confirmed

PMID:32323041i: E-field → insulin w/o glucose; CaVγ4→CaMKII→MafA (PMC9030882i)

Electric fields induce insulin secretion from β-cells WITHOUT glucose via Ca²⁺ channels. CaVγ4→CaMKII→MafA pathway controls β-cell maturity — CaMKII dysregulation causes β-cell identity loss. Connects EMF directly to type 2 diabetes.

10⁻³ m

VK13: EMF → hypothalamic synaptic vesicles↓

✓ Confirmed

Kim 2019i: 835 MHz 12wk → vesicle↓, synapsin I/II↓, synaptotagmin 1↓

835 MHz (12 weeks) reduces synaptic vesicle number, size, and docking in hypothalamus, plus synapsin I/II and synaptotagmin 1 (Ca²⁺ sensor for release). ALL hypothalamic hormone release impaired — explaining simultaneous GnRH, CRH, TRH, GHRH, dopamine disruption.

10⁻² m

VK14: Cortisol↑ → hippocampal atrophy

✓ Confirmed

Sapolsky 2009i: dendritic retraction + neurogenesis↓; cortisol→AD (Frontiers 2026i)

Chronic cortisol causes hippocampal dendritic retraction, neurogenesis cessation, and volume loss. Hippocampus is HPA negative feedback center — its damage removes cortisol braking → cortisol↑↑ (loop S6). Accelerates Alzheimer's progression.

10⁻⁵ m

VK15: EMF → Leydig → StAR↓ → T↓

✓ Confirmed

Multiple: RF → Leydig morphology changes, StAR↓, T↓ dose-dependently

EMF reduces StAR protein in Leydig cells — the rate-limiting step in steroidogenesis. Molecular mechanism behind population-wide T↓ independent of obesity, confirmed by Mazur's weight-stable data.

10⁻⁵ m

VK16: EMF → VGCC → Ca²⁺ → mast cell degranulation

✓ Confirmed

Johansson 2000i: EMF → mast cell changes; cardiac mast cells → arrhythmias (PMC6896164i)

Ca²⁺ triggers mast cell degranulation. EMF → VGCC → Ca²⁺ → mast cell releases histamine + IL-1β + tryptase. Skin biopsies from display users show changes. Cardiac mast cells → arrhythmias. IL-1β from mast cells → KCC2↓ → GABA excitatory longer.

10⁻⁶ m

VK17: RF → sperm calcium/motility; functional transfer to be tested

◐ Partial

2100 MHzi: ESHRE abstract, 50 male rats, 1 h/day for 28 days; calcium/motility differences, no significant mating/live-birth difference

The in-vivo Wistar-Albino rat study included amlodipine 1 mg/kg and reported calcium/motility differences. CatSper gene analysis was unfinished. It does not identify a human sperm response, selective CatSper blockade or premature activation. BERM tests current → calcium timing/ATP → hyperactivation → fertilization as separate transitions. Direct RF gating of human CatSper and heavy-metal × field reproductive synergy remain separate matched experiments.

10⁻⁵ m

VK18: SCN Ca²⁺ oscillation = circadian clock

✓ Confirmed

PMC6170461i: SCN neurons oscillate in Ca²⁺ with circadian rhythm

SCN neurons oscillate in Ca²⁺ concentration with circadian rhythm — Ca²⁺ oscillations ARE the physical basis of the circadian clock. EMF disrupts Ca²⁺ → EMF disrupts the clock itself. SCN is the master pacemaker that synchronizes hypothalamic and peripheral clocks.

10⁻⁷ m

VK19: Inflammation → DA↓ → motivation loss

✓ Confirmed

Berridgei: NAcc DA = 'wanting'; IFN-α → striatal DA↓ → anhedonia (PMC9718669i)

Nucleus accumbens dopamine mediates 'wanting' (motivation) but not 'liking' (pleasure). Inflammation (IFN-α) reduces striatal dopamine causing anhedonia, reversed by L-DOPA. Low tonic DA increases phasic response → screens feel more rewarding with low baseline DA. EMF→inflammation→DA↓→addiction vulnerability.

10⁻⁶ m

VK20: Cav1.2 → OPC differentiation → myelination

✓ Confirmed

PMC6916379i: Cav1.2 KO → hypomyelination; SMF → Cav1.2↑ in OPCs (Sci Rep 2017i)

Cav1.2 (L-type VGCC) is essential for oligodendrocyte precursor cell differentiation and myelination. Cav1.2 knockout causes hypomyelination. Static magnetic field increases Cav1.2/Cav1.3 expression in OPCs. EMF-induced Cav1.2 dysregulation → myelination timing disruption in developing brain.

10⁻⁵ m

VK21: NK cell Ca²⁺ → immune surveillance

✓ Confirmed

Ca²⁺→NFAT1→granzyme B (PLoS ONE 2024i); 50 Hz ELFi→NK↓; 200 kHz TTFieldsi→NK↑

NK cell cytotoxicity is Ca²⁺-dependent: Ca²⁺ influx activates NFAT1 → granzyme B expression. 50 Hz ELF suppresses NK cytotoxicity while 200 kHz TTFields INCREASE it — direct validation of frequency-dependent pathway hierarchy. Same VGCC mechanism, opposite outcomes at different frequencies.

10⁻⁵ m

VK22: Cortisol → GnIH → GnRH↓ → T↓

✓ Confirmed

PMC5380668i: GnIH silencing restored fertility; RF9 restored T in cortisol-treated primates (PMC7946976i)

Stress induces GnIH/RFRP-3 which suppresses GnRH → LH → testosterone. GnIH gene silencing RESTORED fertility in stressed animals. RF9 (GnIH antagonist) RESTORED testosterone in hydrocortisone-treated primates. CRF directly suppresses GnRH pulse generator. Three independent routes to T↓.

10⁻⁶ m

VK23: BDNF hormesis — RF↓ vs ELF↑

✓ Confirmed

RF 2650 MHz → BDNF↓ + GABA↓ (PMC10275548i); ELF 50 Hz → BDNF↑ + neurogenesis↑ (PMC5702423i)

RF-EMF reduces BDNF in hippocampus (2650 MHz, 28 days: BDNF↓, GABA↓, GR↓, corticosterone↑). Postnatal RF (835 MHz) causes dendritic spine loss + memory impairment. Meanwhile ELF 50 Hz INCREASES BDNF and promotes neurogenesis. Frequency-dependent hormesis: same pathway, opposite direction.

10⁻⁵ m

VK24: Per2 → gut barrier → LPS → neuroinflammation

✓ Confirmed

Per2 KO → gut barrier↓ → LPS → hippocampal neurogenesis↓ → depression (PMC12631932i)

Per2 knockout in gut epithelium disrupts barrier function → LPS enters bloodstream → neuroinflammation → hippocampal neurogenesis↓ → depression. Circadian disruption alters gut microbiome (Ruminococcus↑, Lactobacillus↓, LPS-synthesis genes↑). Dual barrier principle: BBB + gut barrier share ZO-1, occludin, claudins.

10⁰ m

VK25: Sleep↓ → T↓ → Walker chain closed

✓ Confirmed

JAMA 2011i: 5h sleep → T -10-15%; meta-analysis confirms (PMID:34801825i)

One week of 5h sleep reduces testosterone by 10-15%, equivalent to 10-15 years of aging. The Walker chain is now closed: EMF→melatonin↓→sleep↓→T↓→neuroprotection↓→more EMF damage. Sleep restriction + EMF predicted to produce superadditive T decline (>25% combined vs ~15% sleep alone).

10⁻⁵ m

VK26: EMF → HPT axis → Dio2/Dio3↓ → hidden hypothyroidism

✓ Confirmed

PMC11507962i: LTE → Dio2/Dio3↓ in hypothalamus; PMID:35963949i: FT3↓ + FT4↑ in ELF workers

EMF reduces Dio2 and Dio3 deiodinase enzymes in the hypothalamus. T4→T3 conversion is impaired → blood T4 appears normal but tissues lack active T3. Standard thyroid tests (TSH, T4) miss this hidden deficiency. FT3/FT4 ratio is the diagnostic key.

10⁻⁸ m

VK27: EMF → epigenetic components → proposed F3 persistence

◐ Partial

Exposure-associated epigenetic changes and non-EMF F3 inheritance are separate components

EMF studies report epigenetic endpoints, while toxicant models establish that some germline changes can persist to F3. Their composition does not demonstrate an EMF-induced F3 phenotype; that direct multigeneration experiment remains open.

10⁻⁷ m

VK28: EMF → ROS → telomeres → aging spiral

✓ Confirmed

PMID:36582083i: radiation → ROS → telomere damage; mel → telomerase + SIRT1 (Front Aging Neurosci 2022i)

EMF→ROS damages telomeres (G-rich sequences are especially vulnerable). Simultaneously EMF→melatonin↓ removes telomerase + SIRT1 protection. Depression = 281 bp shorter telomeres = 7 years accelerated aging. Melatonin is the key anti-aging molecule: it activates telomerase, upregulates SIRT1, and reduces ROS.

10⁻⁸ m

VK29: EMF → oxytocin Ca²⁺ disruption → social bond↓

✓ Confirmed

PMC3197583i: OXT release requires N-type + L-type VGCCs; eNeuro 2025i: PVN Ca²⁺ → OXT

Oxytocin somatodendritic release requires Ca²⁺ influx through both N-type and L-type VGCCs. EMF disrupts VGCC function → OXT release disrupted. L-type is especially important in neonates. Insulin→OXT via Ca²⁺ links metabolic and social systems. Quad lock: T↓×F↑×DA↓×OXT↓ = complete social-reproductive collapse.

10⁻⁵ m

VK30: ELF-priming → α2δ-1↑ → chronic pain WITHOUT neuropathy

✓ Confirmed

PMID:16764990i: α2δ-1 overexpression alone → pain; Br J Pharmacol 2018i: gabapentin blocks α2δ-1

ELF-priming (VK4) upregulates VGCC expression including α2δ-1. α2δ-1 overexpression alone produces neuropathic pain behavior WITHOUT nerve injury. Gabapentinoids (gabapentin, pregabalin) target exactly α2δ-1. The chronic pain epidemic is consistent with population-wide ELF-priming of α2δ-1.

10⁻⁵ m

VK31: ASD = BERM prototype (GABA switch + α2δ + inflammation → E/I↑)

✓ Confirmed

NKCC1/KCC2↑ in ASD (Front Psychiatry 2025i); CACNA2D3i autism gene; bumetanide RCTs

ASD unites three independently verified BERM mechanisms: GABA switch delay (VK6, KCC2↓→GABA excitatory), ELF-priming synaptogenesis (VK4+VK30, α2δ-1↑→E/I↑), and inflammation-driven KCC2 suppression (S9, IL-1β→KCC2↓). CACNA2D3 is an autism susceptibility gene. KCC2 sex dimorphism explains 4:1 male predominance. Bumetanide (NKCC1 blocker) improves ASD symptoms in RCTs.

10⁻⁵ m

VK41: ADHD = second prototype (PFC delay + DA Goldilocks + E/I shift)

✓ Confirmed

Shaw 2007i PNAS: PFC delay 5 yr; Arnsten 2009i: DA inverted U; ASD-ADHD 30-50% comorbidity

ADHD unites three BERM mechanisms: DA deficit in PFC (VK19: striatum DA↓ → attention↓), myelination delay (VK20: Cav1.2→OPC → PFC matures 5 YEARS later), and E/I shift (VK6: KCC2↓). ASD and ADHD share 30-50% comorbidity — same mechanism, different Q values on the excitability spectrum.

10⁻² m

VK42: Shift work → IARC 2A → cancer via melatonin suppression

✓ Confirmed

IARC Monograph 98 2010i; meta-analysis breast cancer OR 2.34i; melatonin antitumor (Reiter 2017i)

IARC classifies shift work as Group 2A (probably carcinogenic) via melatonin suppression. EMF suppresses melatonin through the SAME mechanism (VK3: PGC). If IARC accepts circadian disruption via shift work as 2A, then EMF-induced circadian disruption should carry equal evidential weight.

10⁻⁵ m

VK43: Verapamil → β-cell Ca²⁺ protection in T1D

✓ Confirmed

Forlenza JAMA 2023i RCT N=88: C-peptide +30%; Ovalle Nat Med 2018i; Diabetes Care 2025

Verapamil (Cav1.2 blocker) preserves β-cell function in children with new-onset T1D: C-peptide +30% vs placebo at 52 weeks. Double-blind RCT (N=88, ages 7-17). Confirms VK12: β-cell Ca²⁺ disruption causes identity loss. If blocking Ca²⁺ channels saves β-cells, then Ca²⁺ overload (from EMF) destroys them.

10⁻⁴ m

VK44: Preterm birth = uterine VGCC → nifedipine tocolysis

✓ Confirmed

Cochrane 2014i: nifedipine first-line tocolytic; P4:E2→Cav1.2 (PMC3816733i)

Uterine contractions depend on Ca²⁺ influx through VGCCs. Nifedipine (Ca²⁺ channel blocker) is first-line tocolytic — Cochrane evidence. Progesterone:estrogen ratio regulates Cav1.2 expression in uterus. If Ca²⁺ blockade prevents preterm labor, then Ca²⁺ overload is the cause.

10⁻⁵ m

VK45: ALS = motor neuron Ca²⁺ vulnerability (4th neurodegeneration)

✓ Confirmed

PMC4452055i: motor neuron low Ca²⁺ buffering; Ca²⁺-permeable AMPA; riluzole indirect Ca²⁺↓

Motor neurons have low Ca²⁺ buffering capacity + Ca²⁺-permeable AMPA receptors → selectively vulnerable to Ca²⁺ overload. Riluzole (only ALS drug for decades) works indirectly: Na⁺ block → glutamate↓ → Ca²⁺↓. Fourth neurodegeneration with Ca²⁺ mechanism (after AD, MS, PD). Occupational EMF: OR 1.3-1.7.

10⁻⁶ m

VK46: Gut-brain 5-HT axis (90% serotonin in gut)

✓ Confirmed

Cell Host Microbei: 90% 5-HT in gut; PMC7231603i: Trp→brain; gut melatonin

Over 90% of serotonin is produced in gut enterochromaffin cells. Gut microbiota modulate tryptophan availability to brain → central 5-HT synthesis. Melatonin is also synthesized from serotonin in the gut. IBS-depression comorbidity reflects shared gut-brain 5-HT disruption. Connects S14 (Per2→gut) to S2 (serotonin lock-open).

10⁻⁵ m

VK47: Allergies = mast cell Ca²⁺ degranulation (quadruple sensitization)

✓ Confirmed

ScienceDirect 2011i: Ca²⁺ ionophore → degranulation WITHOUT IgE; env estrogensi → mast cell↑

Mast cell degranulation is Ca²⁺-dependent: Ca²⁺ ionophores trigger degranulation WITHOUT IgE, Ca²⁺ depletion blocks it WITH IgE. Quadruple sensitization: (1) EMF→VGCC→Ca²⁺ in mast cells, (2) environmental estrogens→mast cell sensitization, (3) cortisol→Th1→Th2 shift, (4) gut barrier→LPS→systemic inflammation.

10⁻⁴ m

VK48: Pre-eclampsia = pregnancy Cav1.2 + ROS dysregulation

✓ Confirmed

PMC9774363i: Cav1.2 BP regulation; ET-1→Cav1.2 in placenta; nifedipine for pre-eclampsia

Pre-eclampsia involves Cav1.2 + ROS dysregulation in pregnancy. ET-1 activates Cav1.2 in placental vessels; nifedipine partially blocks this. Ca²⁺ spark frequency reduced in pre-eclampsia → vasodilation↓. Nifedipine used for both tocolysis AND pre-eclampsia hypertension — same Ca²⁺ mechanism in reproductive tissue.

10⁻⁴ m

VK49: Osteoporosis + PEMF hormesis paradox

◐ Partial

Frontiers Endocrinol 2024i: Ca²⁺ channels in bone; PMC11919207i: PEMF → bone growth

Ca²⁺ channels in bone and reported PEMF outcomes are imported L3 components with component-specific evidence labels. BERM hypothesizes a parameter-dependent biological-response optimum: controlled protocols may produce a beneficial Ca²⁺ transient while other regimes may not. The optimum hypothesis belongs only to that imported biological-response model; χ_geo remains a separate L1-derived geometric result, and PEMF evidence does not close the open L0→L2 mapping.

10⁻⁸ m

VK50: Vitamin D → CACNA1C/1D mRNA↓ (10th moderator)

✓ Confirmed

J Neurosci 2001i: VDH→L-VSCC↓; PLoS ONE 2011i: VDR silencing → Cav1.2↑; Transl Psychiatry 2019i

Vitamin D (1,25(OH)₂D₃) downregulates CACNA1C and CACNA1D mRNA — nature's channel blocker. VDR silencing prevents Cav1.2/Cav1.3 downregulation. Vitamin D deficiency → VGCC over-expression = same state as ELF-priming. Triple hit: CACNA1C variant + low vitamin D + EMF = highest risk (schizophrenia). 10th BERM moderator.

10⁻⁶ m

VK51: CatSper = sperm-specific Ca²⁺ channel (5 infertility routes)

✓ Confirmed

RBMO 2014i: knockout = sterile; Nature Comms 2025i: temp-gated Q₁₀=5.1; JCI 2024i: human mutations

Young 2024 identifies human CatSper deficiency as a functional hyperactivation/fertilization defect despite potentially normal routine semen parameters. Calcium clearance and the later oocyte PLCζ signal are separate mechanisms. Hormonal, DNA, tissue and channel changes may share causes and must not be multiplied as five independent effects.

10⁻⁷ m

VK52: Psilocybin = Ca²⁺ cascade reset via 5-HT2A→BDNF→mTOR

✓ Confirmed

Trends Pharmacol Sci 2025i; Science 2023i: intracellular 5-HT2A; Mol Psychiatry 2025i

Psilocybin promotes dendritic spine growth via 5-HT2A→Gq→Ca²⁺→BDNF→mTOR — precisely reversing VK14 (cortisol→dendritic atrophy) and VK23 (BDNF↓). Intracellular 5-HT2A activation required (Science 2023) — serotonin itself cannot access these receptors. A pharmacological RESET of the Ca²⁺-damaged neural architecture.

10⁻⁷ m

VK53: Caffeine = A2A→Ca²⁺ modulation → PD neuroprotection

✓ Confirmed

Frontiers Neurosci 2020i: PD inverse assoc; PMID:11319241i: MPTP protection; J Neurol Sci 2016i

Strong epidemiological inverse association between caffeine and Parkinson's disease. A2A receptor antagonism → DA neuron protection in MPTP/6-OHDA models. Neuroprotection extends beyond PD: stroke, excitotoxicity, α-synuclein clearance. Caffeine is the ONE natural Ca²⁺ modulator whose consumption is INCREASING — potentially compensatory self-medication.

10⁰ m

VK54: Lithium in drinking water → dementia↓ + suicide↓

✓ Confirmed

Int J Bipolar Disord 2024i: 5 studies dementia↓; Br J Psychiatry 2020i: suicide meta; ScienceDirect 2026i: US counties

Higher natural lithium in drinking water is associated with lower dementia and suicide rates at population level. GSK-3β inhibition + CaMKII modulation + BDNF↑ + circadian stabilization = multiple BERM Ca²⁺ cascade nodes. Modern water filtration REMOVES trace lithium — a fifth natural protective mechanism lost.

10⁻⁵ m

VK55: Amygdala hypertrophy ↔ hippocampal atrophy (S17 loop)

✓ Confirmed

PNAS 2008i: single cortisol dose → BLA hypertrophy; PLoS ONE 2012i: opposite BDNF; Neurosci Lett 2023i: persistence

Cortisol produces OPPOSITE effects in amygdala vs hippocampus: BLA gains dendrites while hippocampus loses them. BDNF↑ in amygdala / BDNF↓ in hippocampus under same cortisol. BLA hypertrophy persists 21+ days after stress ends while hippocampal atrophy recovers. S17: cortisol→amygdala↑→anxiety↑→cortisol↑ = self-amplifying anxiety spiral.

10³ m

VK56: Amish = BERM's closest control group (confirmed with reservations)

◐ Partial

STAT 2025i: obesity -89%, T2D -75%; Anderson & Potts 2022i: 126-study review; massive lifestyle confounders

Old Order Amish have dramatically lower rates of every BERM-predicted condition. However, massive confounders (diet, exercise, smoking, community) prevent direct attribution. Cross-validated by Klimentidis (animals gaining weight on controlled diets, p=10⁻⁷) and Mazur (weight-stable T↓). The Amish-Mennonite EMF gradient test would be the critical discriminator.

This register organizes direct components, composed convergence and explicit BERM bridge hypotheses across scales. Source-specific interventions anchor individual links; reception, tissue and aggregation operators retain their assumptions. Direct RF → human CatSper, unexposed-F3 inheritance, organ transfer and endpoint-specific tissue-kernel calibration remain distinct tests. A confirmed component does not establish the full geometry-to-population route.

Seventeen positive feedback loops

The convergence verification revealed seventeen self-amplifying cycles within the chain. The loops form a network: any entry point activates multiple degradation spirals simultaneously. Each loop means that initial EMF effects can progressively worsen without increasing exposure — the system degrades itself.

S1

Monitor feedback resonance

Baby's sound → microphone → RF modulation

RF → VGCC → Ca²⁺ → stronger oscillation

Stronger oscillation → louder sound → more RF modulation

Cascade amplification

Mechanistically coherent, untested as complete loop

S2

Serotonin lock-open

EMF → Ca²⁺ → CaMKII → TPH-2 → 5-HT↓

5-HT↓ → thalamocortical gate OPEN

Open gate → EMF penetrates DEEPER into circuits

More CaMKII disruption → more 5-HT↓ → ...

Each link verified independently

S3

Hypoxia-NKCC1

CSD → local hypoxia → NKCC1↑

NKCC1↑ → GABA more excitatory → γ↓ → Q↑

Q↑ → CSD propagates MORE easily

More CSD → more hypoxia → more NKCC1↑ → ...

NKCC1↑ in hypoxia verified

S4

Walker sleep chain

EMF → melatonin↓ → sleep↓

Sleep↓ → GABA tonic inhibition↓ → γ↓ → Q↑

Q↑ → EMF affects brain MORE

More melatonin↓ → worse sleep → less GABA → ...

Each link verified independently

S5

PGC → BBB spiral

EMF → PGC → melatonin↓

Melatonin↓ → BBB tight junctions↓

BBB↓ → heavy metals enter brain MORE easily

Heavy metals → more PGC → less melatonin → ...

Each link verified independently

S6

Cortisol-hippocampus vortex

EMF → HPA → cortisol↑

Cortisol↑ → hippocampal atrophy

Hippocampus↓ → HPA negative feedback LOST

No braking → cortisol↑↑ → more atrophy → ...

Sapolskyi mechanism verified

S7

BAT metabolic spiral

EMF → BAT PRDM16↓ → thermogenesis↓

Thermogenesis↓ → metabolic syndrome → inflammation

Inflammation → more VGCC sensitivity

More Ca²⁺ disruption → more BAT dysfunction → ...

Mechanistically coherent, animal data available

S8

Testosterone neuroprotection loss

EMF → Leydig → StAR↓ → T↓

T↓ → neuroprotection↓ + synaptic plasticity↓

More vulnerable neurons → more EMF damage

More Leydig damage → less T → ...

T↓ neuroprotection link verified

S9

IL-1β → KCC2 loop

EMF → mast cell → IL-1β release

IL-1β → KCC2 maturation delayed

KCC2↓ → GABA stays excitatory longer → Q↑

Q↑ → more neuronal damage → more IL-1β → ...

KCC2 environmental regulation verified

S10

Hypothalamic multi-axis cascade

EMF → hypothalamic synaptic vesicles↓

Vesicle↓ → GnRH↓ + CRH dysregulation + TRH↓

Multi-hormone deficit → systemic disruption

Systemic stress → more HPA activation → ...

Kim 2019i synaptic changes verified

S11

Circadian clock self-disruption

EMF → SCN Ca²⁺ oscillation disrupted

SCN disrupted → melatonin timing lost → sleep↓

Sleep↓ → Per2↓ in gut + peripheral clocks desync

Desync → more SCN vulnerability → ...

SCN Ca²⁺ oscillation + Per2 gut link verified

S12

NK-cancer-inflammation

ELF → NK cell cytotoxicity↓

NK↓ → cancer surveillance↓ → tumor growth

Tumor → inflammation → more VGCC sensitization

More Ca²⁺ disruption → more NK suppression → ...

NK Ca²⁺ dependence + ELF suppression verified

S13

HPA-HPG cross-spiral

EMF → cortisol↑ → GnIH↑ → T↓

T↓ → neuroprotection↓ → hippocampus vulnerable

Hippocampus↓ → HPA braking lost → cortisol↑↑

More GnIH → more T↓ → ...

RF9 restored T in cortisol-treated primates

S14

Gut-brain inflammation

EMF → melatonin↓ → Per2↓ in gut epithelium

Per2↓ → gut barrier↓ → LPS enters bloodstream

LPS → neuroinflammation → hippocampal neurogenesis↓

Neuroinflammation → more HPA activation → more melatonin↓ → ...

Per2 KO → gut barrier → LPS → depression verified

S15

Melatonin-telomere aging spiral

EMF → melatonin↓ → telomerase↓ + SIRT1↓

Telomerase↓ → telomere shortening → SASP

SASP → inflammation → ROS↑

ROS↑ → more telomere damage → more SASP → ...

Melatonin → telomerase + SIRT1 verified; depression = 7y accelerated aging

S16

Pain-sleep-cortisol spiral

EMF → α2δ-1↑ → central sensitization → chronic pain

Chronic pain → sleep↓ (Walker chain S4)

Sleep↓ → cortisol↑ (HPA S7) + GABA↓

Cortisol↑ → inflammation → more sensitization → depression → sleep↓ → ...

α2δ-1 → pain without injury verified; pain-sleep-cortisol each verified

S17

Amygdala-anxiety spiral

EMF → cortisol↑ (HPA axis, VK11)

Cortisol → BLA hypertrophy + BDNF↑ in amygdala

BLA hypertrophy → anxiety↑ → MORE cortisol

Simultaneously: hippocampus atrophies → HPA brake LOST → cortisol↑↑

Amygdala hypertrophy PERSISTS 21+ days after stress → structural lock-in

Single cortisol dose → BLA hypertrophy verified (PNAS 2008i); persistence verified (Neurosci Lett 2023i)

Consilience assessment

Consilience — independent lines of evidence converging on the same conclusion — is the strongest form of scientific support. BERM exhibits three levels of consilience.

Strong consilience

Independent evidence lines converge

  • Theory premise (Lindgren 2025i) ↔ derived χ_geo and conditional L2 operator [tissue kernel open] ↔ pharmacological Ca²⁺ evidence
  • Genetics (CACNA1C, Sousouri 2025i) ↔ Experimental (López-Martín seizuresi)
  • Epidemiology (Klimentidis 8 speciesi) ↔ Pathology (SIDS 5-HT deficiency)

Moderate consilience

Related evidence lines support each other

  • ELF-priming (Sci. Rep. 2016i) ↔ Gabapentin blocks it (Cell 2009i)
  • PGC ↔ melatonin (r=0.569i) ↔ Pinealectomy → arrhythmiasi
  • Sleep deprivation → GABA↓i (clinical) ↔ EMF → melatonin↓ (animal)

Weak consilience (universality risk)

Ca²⁺ is ubiquitous — some connections may be trivial

  • '25 epidemics with one denominator' — Ca²⁺ IS everywhere
  • Some Ca²⁺ associations may reflect universal biology, not specific EMF causation
  • This is the model's primary epistemic risk

What would falsify the model

A progressive research program must specify what would destroy it. BERM has four tiers of falsification, from complete collapse to clinical irrelevance.

LEVEL 1 — Model collapse

Test

ETH Zürich nimodipine-5G: Ca²⁺ blocker does NOT prevent EMF sleep effect

Consequence

VGCC is not the target → entire cascade collapses

LEVEL 2 — Environmental factor eliminated

Test

Amish data: same health trends as mainstream population

Consequence

EMF is not a significant environmental factor

LEVEL 3 — Key experiment fails

Test

López-Martíni fails to replicate: picrotoxin + GSM does NOT cause seizures

Consequence

The only direct experimental evidence disappears

LEVEL 4 — Clinical irrelevance

Test

EMF reduction intervention produces NO health benefit

Consequence

Model may be mechanistically correct but clinically meaningless

Progressive vs. degenerative

In Lakatos's framework, a research program is progressive if it generates predictions that are subsequently confirmed, producing more empirical content than was put in. It is degenerative if it only accommodates known facts post hoc.

BERM predicted that CACNA1C genotype would modulate EMF response → Sousouri 2025i confirmed (ETH Zürich, double-blind)

BERM predicted that all effective SIDS treatments target Ca²⁺ pathways → verified across caffeine, melatonin, magnesium, oxytocin, bumetanide

BERM predicted that ELF-priming should increase VGCC expression → Sun 2016 (Sci. Rep.)i confirmed

BERM predicted SUDEP and SIDS share a terminal mechanism → CSD → brainstem pathway confirmed for both

BERM predicted that pulse modulation should matter more than SAR → López-Martín 2009i confirmed

Each verification produced MORE than was predicted — unexpected findings at every layer

The model is progressive in Lakatos's sense: it generates predictions → predictions are verified → verification produces MORE content than the model specified. This is the hallmark of a productive research program.

The evolution theory analogy

BERM shares structural features with evolution by natural selection — both are generative mechanisms that predict findings before observation, constrain the search space, and exhibit multi-level convergence.

BERMEvolution theory
Generative mechanism (EMF→VGCC→Ca²⁺→cascades)Generative mechanism (variation→selection→adaptation)
Predicts findings BEFORE lookingPredicts fossils, genes, vestigial structures BEFORE finding them
Constrains the search space (pharmacology, genetics)Constrains the search space (phylogeny, biogeography)
Multi-level convergence (physics → epidemiology)Multi-level convergence (molecules → ecosystems)

CRITICAL DIFFERENCE: Evolution has independent verification (DNA sequencing). BERM still lacks INTERVENTIONAL verification — EMF reduction → health improvement in humans. This is the single most important missing piece.

Derived prediction · L* level

This section describes predictions derived from the BERM framework that have not yet been directly tested. They are presented as testable hypotheses, not established findings.

The convergence verification generates 55 testable predictions covering heavy metal synergy, blood-brain barrier, brown adipose tissue, HPA axis, β-cell, hypothalamic nexus, cortisol-hippocampus, Leydig cell, mast cell, sperm CatSper, NK immune surveillance, BDNF hormesis, gut-brain axis, thyroid Dio2/Dio3, epigenetics, telomere aging, oxytocin, chronic pain, ASD prototype, ADHD, ALS, allergy, vitamin D, PEMF hormesis, psilocybin, caffeine, lithium water, amygdala, and Amish control group mechanisms.

See convergence predictions (METAL-EMF-1–4, CHAIN-1–4, BBB-EMF-1–2, BAT-EMF-1, HPA-EMF-1–2, BETA-EMF-1–2, and more)